Default company panoramic image
E7e26953 6974 4a02 8027 a8a6e5361182

ScarX Therapeutics

ScarX is developing the world's first prescription drug to reduce skin scarring; targeting a market size of over US$10 billion worldwide.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Toronto, ON, Canada
  • Currency USD
  • Founded October 2012
  • Employees 2
  • Website scarxtherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.